. 2024 Oct 31;22(1):501.

doi: 10.1186/s12916-024-03711-6.

A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies

Md Hamidul Huque^{1

2

3}, Scherazad Kootar⁴, Kim M Kiely⁵, Craig S Anderson⁶, Martin van Boxtel⁷, Henry Brodaty⁸, Perminder S Sachdev⁸, Michelle Carlson⁹, Annette L Fitzpatrick¹⁰, Rachel A Whitmer¹¹, Miia Kivipelto^{12

13

14}, Louisa Jorm¹⁵, Sebastian Köhler^{7

16}, Nicola T Lautenschlager^{17

18}, Oscar L Lopez¹⁹, Jonathan E Shaw²⁰, Fiona E Matthews^{21

22}, Ruth Peters^{3

6}, Kaarin J Anstey^{23

24

25}

Affiliations

¹ School of Psychology, University of New South Wales, Kensington, NSW, Australia.
² Neuroscience Research Australia, Randwick, NSW, Australia.
³ University of New South Wales Ageing Futures Institute, University of NSW, Kensington, NSW, Australia.
⁴ The Sydney Children's Hospital Network, Sydney, Australia.
⁵ School of Mathematics and Applied Statistics, and, School of Health and Society , University of Wollongong, Wollongong, NSW, Australia.
⁶ Faculty of Medicine, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
⁷ Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
⁸ Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.
⁹ Johns Hopkins Center On Aging and Health, Johns Hopkins University, Baltimore, USA.
¹⁰ Departments of Family Medicine and Epidemiology, University of Washington, Seattle, WA, USA.
¹¹ Department of Public Health Sciences, University of California, Davis, CA, USA.
¹² Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
¹³ The Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.
¹⁴ Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
¹⁵ Centre for Big Data Research in Health, School of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
¹⁶ Research Institute for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
¹⁷ Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
¹⁸ Older Adult Mental Health Program, Royal Melbourne Hospital Mental Health Service, Parkville, Australia.
¹⁹ Departments of Neurology and Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
²⁰ Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.
²¹ Population Health Sciences Institute, Newcastle University, Newcastle, UK.
²² Institute for Clinical and Applied Health Research (ICAHR), University of Hull, Hull, UK.
²³ School of Psychology, University of New South Wales, Kensington, NSW, Australia. k.anstey@unsw.edu.au.
²⁴ Neuroscience Research Australia, Randwick, NSW, Australia. k.anstey@unsw.edu.au.
²⁵ University of New South Wales Ageing Futures Institute, University of NSW, Kensington, NSW, Australia. k.anstey@unsw.edu.au.

PMID: 39482675
PMCID: PMC11526665
DOI: 10.1186/s12916-024-03711-6

A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies

Md Hamidul Huque et al. BMC Med. 2024.

. 2024 Oct 31;22(1):501.

doi: 10.1186/s12916-024-03711-6.

Authors

Affiliations

¹ School of Psychology, University of New South Wales, Kensington, NSW, Australia.
² Neuroscience Research Australia, Randwick, NSW, Australia.
³ University of New South Wales Ageing Futures Institute, University of NSW, Kensington, NSW, Australia.
⁴ The Sydney Children's Hospital Network, Sydney, Australia.
⁵ School of Mathematics and Applied Statistics, and, School of Health and Society , University of Wollongong, Wollongong, NSW, Australia.
⁶ Faculty of Medicine, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
⁷ Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
⁸ Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.
⁹ Johns Hopkins Center On Aging and Health, Johns Hopkins University, Baltimore, USA.
¹⁰ Departments of Family Medicine and Epidemiology, University of Washington, Seattle, WA, USA.
¹¹ Department of Public Health Sciences, University of California, Davis, CA, USA.
¹² Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
¹³ The Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.
¹⁴ Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
¹⁵ Centre for Big Data Research in Health, School of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
¹⁶ Research Institute for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
¹⁷ Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
¹⁸ Older Adult Mental Health Program, Royal Melbourne Hospital Mental Health Service, Parkville, Australia.
¹⁹ Departments of Neurology and Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
²⁰ Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.
²¹ Population Health Sciences Institute, Newcastle University, Newcastle, UK.
²² Institute for Clinical and Applied Health Research (ICAHR), University of Hull, Hull, UK.
²³ School of Psychology, University of New South Wales, Kensington, NSW, Australia. k.anstey@unsw.edu.au.
²⁴ Neuroscience Research Australia, Randwick, NSW, Australia. k.anstey@unsw.edu.au.
²⁵ University of New South Wales Ageing Futures Institute, University of NSW, Kensington, NSW, Australia. k.anstey@unsw.edu.au.

PMID: 39482675
PMCID: PMC11526665
DOI: 10.1186/s12916-024-03711-6

Abstract

Background: We aimed to develop risk tools for dementia, stroke, myocardial infarction (MI), and diabetes, for adults aged ≥ 65 years using shared risk factors.

Methods: Data were obtained from 10 population-based cohorts (N = 41,755) with median follow-up time (years) for dementia, stroke, MI, and diabetes of 6.2, 7.0, 6.8, and 7.4, respectively. Disease-free participants at baseline were included, and 22 risk factors (sociodemographic, medical, lifestyle, laboratory biomarkers) were evaluated. Two risk tools (DemNCD and DemNCD-LR based on Fine and Gray sub-distribution and logistic regression [LR], respectively) were developed and validated. Predictive accuracies of these risk tools were assessed using Harrel's C-statistics and area under the curve (AUC) and 95% confidence interval (CI). Model calibration was conducted using Hosmer-Lemeshow goodness of fit test along calibration plots.

Results: Both the DemNCD and DemNCD-LR resulted in similar predictive accuracy for each outcome. The overall AUC (95% CI) for dementia, stroke, MI, and diabetes risk tool were 0·68 (0·65, 0·70), 0·58 (0·54, 0·61), 0·65 (0·61, 0·68), and 0·68 (0·64, 0·72), respectively, for males. For females, these figures were 0·65 (0·63, 0·67), 0·55 (0·52, 0·57), 0·65 (0·62, 0·68), and 0·61 (0·57, 0·65).

Conclusions: The DemNCD is the first tool to predict both dementia and multiple cardio-metabolic diseases using comprehensive risk factors and provided similar predictive accuracy to existing risk tools. It has similar predictive accuracy as tools designed for single outcomes in this age-group. DemNCD has the potential to be used in community and clinical settings as it includes self-reported and routinely available clinical measures.

Keywords: Dementia; Diabetes; Heart attack; Primary prevention; Risk factors; Risk prediction; Risk tool; Stroke.

PubMed Disclaimer

Conflict of interest statement

JES has received honoraria for scientific advisory, lectures, and clinical research from Pfizer; Roche; Zuellig Pharma; Astra Zeneca; Sanofi; Novo Nordisk; MSD; Eli Lilly; Abbott; Mylan; Boehringer Ingelheim. CSA has received grants from Takeda.

Figures

**Fig. 1**
AUC of the DemNCD-LR tool following logistic regression associated with the diagnosis of dementia, MI, stroke, and diabetes

See this image and copyright information in PMC

References

1. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46. - PMC - PubMed
1. World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. 2019. - PubMed
1. Tai XY, Veldsman M, Lyall DM, Littlejohns TJ, Langa KM, Husain M, et al. Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study. Lancet Healthy Longev. 2022;3(6):e428–36. - PMC - PubMed
1. Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing Commission. Lancet. 2024;404:572. - PubMed
1. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–81. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

P30 AG072972/AG/NIA NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies

Affiliations

A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical